Human peroxisome proliferator activated receptor γ

Details Human peroxisome proliferator activated receptor γ Human peroxisome proliferator activated receptor γ

2006-10-03

2006-10-03

Pak, Michael (Department: 1646)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

07115728

ABSTRACT:
The present invention relates to a novel human peroxisome proliferator activated receptor, hPPARγ. hPPARγ differs from the mouse peroxisome proliferator activated receptor γ in the nucleotide sequence and the amino acid sequence. The invention provides isolated, purified, enriched or recombinant nucleic acid encoding hPPARγ polypeptides and vectors containing thereof, cells transformed with such vectors, and methods of screening for agonists and antagonists of hPPARγ polypeptides. The invention also provides isolated, purified, enriched, or recombinant hPPARγ polypeptides, antibodies having specific binding affinity to hPPARγ polypeptides, and hybridomas producing such antibodies.

REFERENCES:
patent: 3845089 (1974-10-01), Henrick
patent: 3884758 (1975-05-01), Green
patent: 4105681 (1978-08-01), Bollag et al.
patent: 4193931 (1980-03-01), Loeliger
patent: 4215215 (1980-07-01), Bollag et al.
patent: 4534979 (1985-08-01), Love et al.
patent: 4648996 (1987-03-01), Aig et al.
patent: 4783549 (1988-11-01), Lang et al.
patent: 4833254 (1989-05-01), Berlin et al.
patent: 4879284 (1989-11-01), Land et al.
patent: 4892940 (1990-01-01), Maignan et al.
patent: 4977276 (1990-12-01), Berlin et al.
patent: 5130333 (1992-07-01), Pan et al.
patent: 5198567 (1993-03-01), Lang et al.
patent: 5219888 (1993-06-01), Katocs, Jr. et al.
patent: 5264372 (1993-11-01), Beaumont et al.
patent: 5304575 (1994-04-01), Beck
patent: 5441971 (1995-08-01), Sohda et al.
patent: 5508164 (1996-04-01), Kausch et al.
patent: 5512683 (1996-04-01), Klaus et al.
patent: 5654338 (1997-08-01), Metivier
patent: 5686596 (1997-11-01), Mukherjee et al.
patent: 5700836 (1997-12-01), Klaus et al.
patent: 5705167 (1998-01-01), Bernardon et al.
patent: 5726041 (1998-03-01), Chrespi et al.
patent: 5728739 (1998-03-01), Ailhaud et al.
patent: 5763487 (1998-06-01), Bernardon
patent: 5861274 (1999-01-01), Evans et al.
patent: 5968908 (1999-10-01), Epstein et al.
patent: 5972881 (1999-10-01), Heyman et al.
patent: 5977125 (1999-11-01), Hibi et al.
patent: 6017924 (2000-01-01), Edwards et al.
patent: 6028052 (2000-02-01), Heyman et al.
patent: 6200802 (2001-03-01), Greene et al.
patent: 6228862 (2001-05-01), Heyman et al.
patent: 6294559 (2001-09-01), Smith
patent: 6316404 (2001-11-01), Heyman et al.
patent: 6521633 (2003-02-01), Heyman et al.
patent: 6534516 (2003-03-01), Edwards et al.
patent: 6545049 (2003-04-01), Canan-Koch et al.
patent: 6815168 (2004-11-01), Greene et al.
patent: 2002/0193291 (2002-12-01), Heyman et al.
patent: 2004/0019072 (2004-01-01), Canan-Koch et al.
patent: 2004/0106135 (2004-06-01), Mukherjee et al.
patent: 2819213 (1987-09-01), None
patent: 0169571 (1986-01-01), None
patent: 0253393 (1988-01-01), None
patent: 0266992 (1988-05-01), None
patent: 0 305 890 (1989-03-01), None
patent: 0679628 (1995-11-01), None
patent: 0698392 (1996-02-01), None
patent: 0718285 (1996-06-01), None
patent: 0552624 (1997-07-01), None
patent: 0568898 (1998-04-01), None
patent: 0641759 (1998-12-01), None
patent: 0873295 (2003-04-01), None
patent: 1336600 (2003-08-01), None
patent: 0859608 (2004-02-01), None
patent: 1426048 (2004-06-01), None
patent: 2390428 (1978-12-01), None
patent: 2719041 (1995-10-01), None
patent: 2719042 (1995-10-01), None
patent: 2729664 (1996-07-01), None
patent: 2188634 (1987-10-01), None
patent: 2197316 (1988-05-01), None
patent: 05 194 209 (1993-08-01), None
patent: 83/00930 (1983-03-01), None
patent: 89/04489 (1989-05-01), None
patent: 91/12258 (1991-08-01), None
patent: 93/09236 (1993-05-01), None
patent: 93/15740 (1993-08-01), None
patent: 93/21146 (1993-10-01), None
patent: 94/12880 (1994-06-01), None
patent: 94/15901 (1994-07-01), None
patent: 94/15902 (1994-07-01), None
patent: 94/17796 (1994-08-01), None
patent: 95/04036 (1995-02-01), None
patent: 95/07694 (1995-03-01), None
patent: 95/07697 (1995-03-01), None
patent: WO 95/11974 (1995-05-01), None
patent: WO 95/18533 (1995-07-01), None
patent: WO 96/01317 (1996-01-01), None
patent: 96/05165 (1996-02-01), None
patent: 96/13478 (1996-05-01), None
patent: 96/20913 (1996-07-01), None
patent: 96/23884 (1996-08-01), None
patent: WO 96/33724 (1996-10-01), None
patent: 97/10813 (1997-03-01), None
patent: 97/10819 (1997-03-01), None
patent: 97/12853 (1997-04-01), None
patent: 97/25042 (1997-07-01), None
patent: 97/33881 (1997-09-01), None
patent: 98/05331 (1998-02-01), None
Tontonoz et al. (1994) Genes and Development 8:1224-1234.
Chen et al. (1993) Biochemical and Biophysical Research Communications 196:671-677.
Sher et al. (1993) Biochemistry 32:5598-5604.
Kliewer et al. (1994) Proc Natl. Acad. Sci. USA 91:7355-7359.
Stratagene (1994) pp. 150-155.
Wallace et al. (1987) Methods in Enzymology 152:432-442.
Alihaud, et al., “Cellular and Molecular Aspects of Adipose Tissue Development,”Ann. Rev. Nutr., 12:207-233 (1992).
Aperlo, C., et al., “cDNA Cloning and Characterization of the Transcriptional Activities of the Hamster Peroxiosme Proliferator-Activated Receptor HaPPARgamma,” Gene., 162:297-302 (1995).
Auwerx, et al., “Transcriptional Activation of the Lipoprotein Lipase and Apolipoprotein E Genes Accompanies Differentiation in Some Human Macrophage-like Cell Lines,”Biochem., 27:2651-2655 (1988).
Beers, et al., “The Merk manual of Diagnosis and Therapy.” Seventh Edition, 1999. Merck Research Laboratories, Whitehouse Station, NJ., 58-62.
Chawla, “Induction of Rev-ErbAα, an Orphan Receptor Encoded on the Opposite Strand of the α-Thyroid Hormone receptor Gene, during Adipocyte Differentiation,” J. Biol. Chem., 268(22):16265-69 (1993).
Chiffelle and Putt, :Histochemical Procedures Sudan Colorants in Propylene Glycol, inSelected Histochemical and Hisopatholigical Methods, Charles C. Thomas, Publisher, Springfield, Ill, pp. 329-333 (1996).
Davidson, et al., “A Model System forin vivoGene Transfer Into the Central Nervous System Using an Adenoviral Vector,”Nature Genetics, 3:219-223 (1993).
Forman, et al., “15-Deoxy-Δ12 14- Prostaglandin J2is a Ligand for the Adipocyte Determination Factor PPARγ,” Cell, 83:803-812 (1995).
Green, S., “PPAR: A Mediator of Peroxisome Proliferator Action,”Mutation Research, 333(1,2):101-109 (1995).
Greene, et al., “Isolation of the Human Peroxisome Proliferator Activated Receptor Gamma cDNA: Expression in Hematopoietic Cells and Chromosomal Mapping,”Gene Expression, 4:281-299, (1995).
Kiyoto, “Toward The Treatment of Obesity: Role of PPARγ in Adipogenisis,”Sch. Pharm. Sci., Toho Univ., Funabashi, 274 Japan Tanpakushitsu Kakusan Koso 40(13):1936-41 (1995) (Japanese article with English Abstract).
Kliewer, et al., “Convergence Of9-CisRetinoic Acid And Peroxisome Proliferator Signaling Pathways Through Heterodimer Formation Of Their Receptors,”Nature, 358:771-774 (1992).
Le Gal La Salle, et al., “An Adenovirus Vector for Gene Transfer into Neurons and Gila in the Brain,”Science, 259:988-990 (1993).
Lehmann, et al., “An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ(PPARγ)*,”J. Biol. Chem., 270(22):12953-12956 (1995).
Leibel, et al., Chenges in Energy Expenditure Resulting from Altered Body Weight,The New Eng., J. of Med., 332(10):621-628 (1995).
MacDougald, O.A., et al., “Transcriptional Regulation of Gene Expression During Adipocyte Differentiation,”Ann. Rev. Biochem., 64:345-373 (1995).
Quantin, et al., “Adenovirus as an Expression Vector in Muscle Cellsin vivo,” Pro. Natl. Acad. Sci. USA, 89:2581-2584 (1992).
Salazar-Olivo, “Inhibition of 3T3 Adipogenisis by Retinoic Acid is not Mediated by Cytoplasmic Retinoic Acid-Binding Protein,”Biochem. and Biophysical Res. Comm., 204(1):257-263 (1994).
Stratford-Perricaudet, et al., “Widespread Long-term Gene Transfer to Mouse Skeletal Muscles and Heart,”J. Clin. Invest, 90:626-630 (1992).
Thompson,Selected Histochemi

Affiliated with

Also associated with

Rating

Human peroxisome proliferator activated receptor γ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human peroxisome proliferator activated receptor γ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human peroxisome proliferator activated receptor γ will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3709262